SJS Investment Consulting’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$919 Sell
13
-329
-96% -$17.8K ﹤0.01% 2061
2026
Q1
$17.9K Sell
342
-443
-56% -$26.6K ﹤0.01% 696
2025
Q4
$46.2K Sell
785
-151
-16% -$9.18K 0.01% 388
2025
Q3
$52.1K Buy
936
+935
+93,500% +$50.1K 0.01% 269
2025
Q2
$52 Sell
1
-7
-88% -$352 ﹤0.01% 1513
2025
Q1
$470 Sell
8
-7
-47% -$474 ﹤0.01% 1268
2024
Q4
$1.08K Sell
15
-5
-25% -$367 ﹤0.01% 972
2024
Q3
$1.6K Buy
20
+2
+11% +$150 ﹤0.01% 900
2024
Q2
$1.29K Buy
18
+1
+6% +$74 ﹤0.01% 932
2024
Q1
$1.2K Buy
17
+2
+13% +$143 ﹤0.01% 971
2023
Q4
$1.16K Buy
15
+3
+25% +$198 ﹤0.01% 892
2023
Q3
$817 Sell
12
-1
-8% -$79 ﹤0.01% 1018
2023
Q2
$1.06K Buy
13
+5
+63% +$402 ﹤0.01% 881
2023
Q1
$594 Sell
8
-12
-60% -$925 ﹤0.01% 1096
2022
Q4
$1.66K Buy
20
+12
+150% +$953 ﹤0.01% 709
2022
Q3
$1K Buy
+8
New +$691 ﹤0.01% 915
2022
Q1
$0 Buy
+4
New +$413 ﹤0.01% 1307

Other funds holding TECH

SJS Investment Consulting's TECH Position: Q2 2026 in Review

SJS Investment Consulting reduced its Bio-Techne (TECH) stake by 96% in Q2 2026, selling an estimated $17.8K and leaving 13 shares worth $919. The position accounts for ﹤0.01% of the portfolio, ranked #2061.

SJS Investment Consulting first reported a position in TECH in Q1 2022 and has held it in 17 quarters since. The position peaked at $52.1K in Q3 2025. 596 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • SJS Investment Consulting held 13 shares of Bio-Techne worth $919 as of Q2 2026.
  • SJS Investment Consulting sold 329 Bio-Techne shares in Q2 2026, an estimated $17.8K.
  • Bio-Techne made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #2061 holding.
  • SJS Investment Consulting first reported a position in Bio-Techne in Q1 2022 and has held it in 17 quarters since.
  • SJS Investment Consulting's Bio-Techne position peaked at $52.1K in Q3 2025.
  • 596 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.